377 related articles for article (PubMed ID: 16034072)
1. Human dendritic cells: potent antigen-presenting cells at the crossroads of innate and adaptive immunity.
Rossi M; Young JW
J Immunol; 2005 Aug; 175(3):1373-81. PubMed ID: 16034072
[TBL] [Abstract][Full Text] [Related]
2. Human dendritic cell subsets for vaccination.
Dubsky P; Ueno H; Piqueras B; Connolly J; Banchereau J; Palucka AK
J Clin Immunol; 2005 Nov; 25(6):551-72. PubMed ID: 16380819
[TBL] [Abstract][Full Text] [Related]
3. Dendritic type, accessory cells within the mammalian thymic microenvironment. Antigen presentation in the dendritic neuro-endocrine-immune cellular network.
Bodey B; Bodey B; Kaiser HE
In Vivo; 1997; 11(4):351-70. PubMed ID: 9292303
[TBL] [Abstract][Full Text] [Related]
4. Antigen presentation by dendritic cells and their significance in antineoplastic immunotherapy.
Bodey B; Siegel SE; Kaiser HE
In Vivo; 2004; 18(1):81-100. PubMed ID: 15011756
[TBL] [Abstract][Full Text] [Related]
5. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
[TBL] [Abstract][Full Text] [Related]
6. Dendritic cells in transplantation and immune-based therapies.
Young JW; Merad M; Hart DN
Biol Blood Marrow Transplant; 2007 Jan; 13(1 Suppl 1):23-32. PubMed ID: 17222766
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells and immunotherapy for cancer.
Chang DH; Dhodapkar MV
Int J Hematol; 2003 Jun; 77(5):439-43. PubMed ID: 12841381
[TBL] [Abstract][Full Text] [Related]
8. Silencing of SOCS1 enhances antigen presentation by dendritic cells and antigen-specific anti-tumor immunity.
Shen L; Evel-Kabler K; Strube R; Chen SY
Nat Biotechnol; 2004 Dec; 22(12):1546-53. PubMed ID: 15558048
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells and the control of immunity: enhancing the efficiency of antigen presentation.
Steinman RM
Mt Sinai J Med; 2001 May; 68(3):160-6. PubMed ID: 11373688
[TBL] [Abstract][Full Text] [Related]
10. Interferon gamma stimulates cellular maturation of dendritic cell line DC2.4 leading to induction of efficient cytotoxic T cell responses and antitumor immunity.
He T; Tang C; Xu S; Moyana T; Xiang J
Cell Mol Immunol; 2007 Apr; 4(2):105-11. PubMed ID: 17484804
[TBL] [Abstract][Full Text] [Related]
11. Induction of vigorous helper and cytotoxic T cell as well as B cell responses by dendritic cells expressing a modified antigen targeting receptor-mediated internalization pathway.
You Z; Huang XF; Hester J; Rollins L; Rooney C; Chen SY
J Immunol; 2000 Oct; 165(8):4581-91. PubMed ID: 11035100
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells as a tool to combat infectious diseases.
Moll H
Immunol Lett; 2003 Jan; 85(2):153-7. PubMed ID: 12527222
[TBL] [Abstract][Full Text] [Related]
13. Ins and outs of dendritic cells.
Schuurhuis DH; Fu N; Ossendorp F; Melief CJ
Int Arch Allergy Immunol; 2006; 140(1):53-72. PubMed ID: 16534219
[TBL] [Abstract][Full Text] [Related]
14. Genetic modification of dendritic cells and its application for cancer immunotherapy.
Nishioka Y; Hua W; Nishimura N; Sone S
J Med Invest; 2002 Feb; 49(1-2):7-17. PubMed ID: 11901764
[TBL] [Abstract][Full Text] [Related]
15. Antigen presentation and dendritic cell biology in malaria.
Stevenson MM; Urban BC
Parasite Immunol; 2006; 28(1-2):5-14. PubMed ID: 16438671
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy based on dendritic cells pulsed with CTPFoxM1 fusion protein protects against the development of hepatocellular carcinoma.
Su H; Li B; Zheng L; Wang H; Zhang L
Oncotarget; 2016 Jul; 7(30):48401-48411. PubMed ID: 27351282
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells: nature and classification.
Sato K; Fujita S
Allergol Int; 2007 Sep; 56(3):183-91. PubMed ID: 17646733
[TBL] [Abstract][Full Text] [Related]
18. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases.
Specht JM; Wang G; Do MT; Lam JS; Royal RE; Reeves ME; Rosenberg SA; Hwu P
J Exp Med; 1997 Oct; 186(8):1213-21. PubMed ID: 9334360
[TBL] [Abstract][Full Text] [Related]
19. Tumor-specific CD4+ T cells are activated by "cross-dressed" dendritic cells presenting peptide-MHC class II complexes acquired from cell-based cancer vaccines.
Dolan BP; Gibbs KD; Ostrand-Rosenberg S
J Immunol; 2006 Feb; 176(3):1447-55. PubMed ID: 16424172
[TBL] [Abstract][Full Text] [Related]
20. IFN-alpha in the generation of dendritic cells for cancer immunotherapy.
Santini SM; Lapenta C; Santodonato L; D'Agostino G; Belardelli F; Ferrantini M
Handb Exp Pharmacol; 2009; (188):295-317. PubMed ID: 19031032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
